e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting
Giorgia Sulis, Angelica Agliati, Gabriele Pinsi, Giordano Bozzola, Pierfranco Foccoli, Maurizio Gulletta, Silvio Caligaris, Lina R. Tomasoni, Issa El-Hamad, Alberto Matteelli
Source:
Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017
Journal Issue:
March
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Giorgia Sulis, Angelica Agliati, Gabriele Pinsi, Giordano Bozzola, Pierfranco Foccoli, Maurizio Gulletta, Silvio Caligaris, Lina R. Tomasoni, Issa El-Hamad, Alberto Matteelli. Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting. Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012
Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012
Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?
Source: Eur Respir J 2015; 45: 549-554
Year: 2015
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013
Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding
Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021
Year: 2021
Effect of history of tuberculosis on specificity of Xpert MTB/RIF
Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020
Year: 2020
A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay
Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018
Year: 2019
Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012
The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying
mycobacterium tuberculosis
during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals
Source: Eur Respir J 2016; 47: 575-587
Year: 2016
Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019
Year: 2019
Is smear microscopy obsolete in the era of Xpert MTB/Rif?
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Sensitivity of Xpert MTB/RIF in induced sputum in smear negative pulmonary tuberculosis patients?
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept